Medsource 
Dealstreet

ELP acts on Medsource fund raise from private equity firm Xponentia Capital Partners

Pursuant to the fundraise Xponentia holds a minority stake in Medsource.

Bar & Bench

Leading In-Vitro Diagnostics (IVD) manufacturer Medsource Ozone Biomedicals Private Limited has raised an undisclosed amount from private equity firm Xponentia Capital Partners (Xponentia).

Economic Laws Practice advised Xponentia. The team included Partner Abhishek Sanyal and Senior Associate Jishnu Dhar and Associate Daryl Menezes.

Pursuant to this fundraise Xponentia holds a minority stake in Medsource.

Medsource is one of India’s largest manufacturers of IVD products supplying specialized products to labs pan-India as well exporting to over 35+ countries.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

NYAI launches NYAI AI Studio: India’s first Agentic AI Infrastructure Platform for legal and compliance

CAM, TT&A, JSA, Sidley Austin act on AceVector ₹420 crore IPO

HSA Advocates advises Piramal Finance on ₹266 crore financing for Solitaire VTP Group’s residential projects in Pune

VERTICES PARTNERS advises PLIX as Marico acquires additional stake for ₹1,012 crore

Shardul Amarchand Mangaldas advises Mubadala on divestment of stake in Cube Highways Trust

SCROLL FOR NEXT